Richard Siegfried, MD
Pain Medicine · la Crosse, WINPI 1366522682
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,517 of the $10,152 with a category attached, or 64.2%. It is spread thinly across 17 manufacturers, the largest accounting for just 22.3%. Reporting peaked in 2019 at $3,149 and has fallen 93.2% since, to $214 in 2025.
Across 181 payments — averaging $56.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MML US, Inc.$2K
- Abbott$2K
- Vertiflex, Inc.$2K
- SPR Therapeutics, Inc$2K
- Boston Scientific$510
- Medtronic$496
- plus $920 from 11 others
What the payments were for
- Travel & lodging$3,63536%
- Food & beverage$6,51764%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MML US, Inc. | 17 | $2,267 |
| Abbott | 103 | $2,203 |
| Vertiflex, Inc. | 8 | $2,066 |
| SPR Therapeutics, Inc | 6 | $1,690 |
| Boston Scientific | 16 | $510 |
| Medtronic(2 entities) | 7 | $496 |
| Relievant Medsystems, Inc. | 4 | $300 |
| Nalu Medical, Inc. | 3 | $123 |
| Stryker | 2 | $103 |
| Si-bone, Inc. | 2 | $97 |
| Globus Medical | 1 | $87 |
| Vertos Medical, Inc. | 2 | $63 |
| Fidia Pharma USA Inc. | 3 | $61 |
| AbbVie(2 entities) | 4 | $54 |
| Nevro Corp. | 1 | $15 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Stratus Medical, LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$1,816
- ReActiv8$1,738
- SPRINT PNS System$1,036
- Intracept$572
- INTELLIS ADAPTIVESTIM$265
- Proclaim Family of SCS IPGs$244
- Neuromodulation Dspsbls and Accs$215
- PROCLAIM$142
- VECTRIS$132
- Superion Indirect Decompression System$108
How this compares
$10,152 in reported general payments places this provider in the 75th percentile of 82 pain medicine providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 12 | $90 |
| Methylprednisolone | 19 | $63 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in la Crosse
- David Dahlla Crosse$5K
- Allison Taylorla Crosse$4K
- Alaa Abd-ElsayedMadison$1.3M
- Michael JungWest Bend$339K
- Frederick FreitagMadison$157K
- Atit ShahSheboygan$76K
- Thomas FaullMadison$66K
- Ammar MahmoudNeenah$57K
- Jeremy ScarlettSheboygan$40K
- Thomas StaussGreenfield$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.